MedPath

The Role of Doppler Ultrasound in Assessment of Local Factors Affecting Maturation of Arteriovenous Fistula in Hemodialysis Patient

Not Applicable
Conditions
Doppler Ultrasound in Arteriovenous Fistula Preoperative Evaluation and Post-operative Periodic Monitoring
Interventions
Diagnostic Test: doppler ultrasound
Registration Number
NCT05082792
Lead Sponsor
Sohag University
Brief Summary

the long term survival of the chronic kidney disease (CKD) patients depends on the adequacy of dialysis via good vascular access. the arteriovenous fistula (AVF) is the preferred vascular access for hemodialysis. pre-operative evaluation and periodic monitoring of the AVF after creation with well-defined applied criteria by color doppler ultrasound (CDUS) will help to reduce rate of access failure and achieve better cumulative patency rate of fistulas.

Detailed Description

In recent years, the improvement in the diagnosis and treatment of chronic kidney disease (CKD) has led to increase the number of patients who need hemodialysis, adequacy of which depends upon the appropriately placed vascular access. Although the arteriovenous fistula (AVF) is the preferred vascular access for hemodialysis, there is still a high rate of failure to mature in clinical practice. To increase the use of AVFs, especially in the co-morbid patients, a thorough pre-operative evaluation and periodic monitoring after AVF creation by color doppler ultrasound (CDUS) allows placement of AVF in higher proportion of patients, and early detection of access dysfunction with subsequent intervention that reduce the rate of access failure.

Doppler ultrasound is the main imaging modality for assessment of dialysis access circuits as its gives information on the morphological criteria and evaluates the inflow and outflow flows. CDUS is non-invasive modality, of low cost, not using ionizing radiation or iodinated contrast media.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
50
Inclusion Criteria

CKD and ESRD patients on hemodialysis, in whom native arteriovenous fistula operation is needed

  • both sexes are included.
  • age group from 15-80years
  • upper limb arteriovenous fistula only.
  • native arteriovenous fistula.
  • surgically succeeded AVF
Exclusion Criteria

we will exclude:

  • patients refused to be in the research.
  • Patients with AVF not in the upper limbs.
  • Patient of age less than 15years and above 80years.
  • patients with synthetic grafts.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
doppler US for native AVF in upper limbdoppler ultrasoundcreation of native arteriovenous fistula in upper limb in chronic kidney disease patients on hemodialysis
Primary Outcome Measures
NameTimeMethod
maturation of AVF6 months

maturation is considered successful if the fistula patent has a diameter \>6mm, located \<6mm maximum depth from skin surface, with PSV 400cm/s, flow volume 600ml/min, within 6 weeks post-surgery

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Sohag University

🇪🇬

Sohag, Egypt

© Copyright 2025. All Rights Reserved by MedPath